Furthermore, our study demonstrated that NGAL levels have a prognostic value in STEMI patients, regardless of the development or exacerbation of renal failure, as shown in a regression model adjusted for both chronic renal failure and AKI. This evidence concerns the gene LCN2 and kidney failure.